Ulixertinib (hydro<wbr>chloride)

Ulixertinib (hydrochloride)

CAT N°: 18298
Price:

From 43.00 36.55

Ulixertinib is a reversible ERK1/2 inhibitor that demonstrates an IC50 value of V600E mutation, it has been reported to reduce the levels of phosphorylated ERK2 and the downstream kinase RSK (IC50s = 4.1 and 0.14 ?M, respectively).{31542} Ulixertinib has also been shown to inhibit A375 cell proliferation with an IC50 value of 180 nM.{31542}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide, monohydrochloride
  • Correlated keywords
    • 869886-67-9 ERK1/2 ERK1 ERK2 ERK-1 ERK-2 extracellular-signal-regulated kinase BVD523 VRT752271 A-375 BRaf BRafV600E BRaf-V600E
  • Product Overview:
    Ulixertinib is a reversible ERK1/2 inhibitor that demonstrates an IC50 value of V600E mutation, it has been reported to reduce the levels of phosphorylated ERK2 and the downstream kinase RSK (IC50s = 4.1 and 0.14 ?M, respectively).{31542} Ulixertinib has also been shown to inhibit A375 cell proliferation with an IC50 value of 180 nM.{31542}

We also advise you